NAMPT and myocardial infarction: Visfatin could counteract H2O2-induced apoptotic damage in H9c2 cardiomyocytes via AMPK activation [18] while the pharmacological inhibition of Nampt could reduce neutrophilic inflammation- and oxidative stress-mediated tissue damage in early phases of reperfusion after a myocardial infarction [19].